Search Results 121-130 of 17653 for ulcerative colitis

  1. The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease - Mayo Clinic

    While small bowel CE has been fairly well studied in CD , colon capsule endoscopy (CCE) for ulcerative colitis (UC) has not been as well studied. Therefore ...

  2. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview · Participation eligibility · Participating Mayo Clinic locations.

  3. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  4. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...

  5. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  6. Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Publications. See a list of publications about pouchitis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine ...

  7. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    About this study ... Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon ...

  8. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

  9. Mayo Clinic: Patients with Inflammatory Bowel Disease at Higher Risk for Stroke and Heart Attack

    11–16, in San Diego. More than 1.5 million Americans have Crohn's disease or ulcerative colitis , the most common forms of inflammatory bowel disease (IBD).

  10. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    ... ulcerative colitis treatment from the United States commercial payer perspective. ... Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: ...